Sumbul Beg, MD
Endo in a Bite
This podcast from EZ Endo Prep delivers concise, high yield endocrinology content to help you study smarter and practice with confidence. Each episode breaks down complex topics into manageable pieces, making it ideal for endocrinology fellows and practicing endocrinologists. Whether you're preparing for boards or staying sharp in clinic, Dr. Sumbul Beg, MD brings exam ready pearls and real world relevance straight to your ears.
Be sure to visit the podcast's website and support the creator: ezendoprep.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Revised 2025 ESE Clinical Practice Guideline on the Treatment of Chronic Hypoparathyroidism in Adults (Part 1) 16.11.2026 7:53
In this episode, we review the revised 2025 European Society of Endocrinology (ESE) Clinical Practice Guideline on the treatment of chronic hypoparathyroidism in adults. Topics include the pathophysiology of hypoparathyroidism as a dual hormone deficiency state, diagnostic criteria, the importance of magnesium, the updated definition of postsurgical chronic hypoparathyroidism, surgical and nonsurg...
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 9) 09.11.2026 10:54
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on connected insulin pens, insulin patches, continuous ketone monitoring, telemedicine, and the future of diabetes technology. Topics include smart pen features, missed insulin doses and glycemic control, the benefits and limitations of insulin patches, continu...
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 8) 02.11.2026 8:44
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on mealtime management with automated insulin delivery. Topics include precise carbohydrate counting, qualitative meal estimation, meal announcement strategies, user initiated bolus behavior, timing of mealtime boluses, carbohydrate entry before meals, injectio...
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 7) 26.10.2026 7:08
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on the continuation of insulin pump and automated insulin delivery therapy during hospitalization and procedures. Topics include criteria for continuing conventional pump therapy, requirements for continued AID use, point of care glucose monitoring, transitioni...
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 6) 19.10.2026 8:55
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on automated insulin delivery beyond standard type 1 diabetes care. Topics include AID use during pregnancy, pregnancy specific glucose targets, evidence from pregnancy trials, differences among AID systems, AID in type 2 diabetes, glycemic outcomes, high insul...
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 5) 12.10.2026 9:00
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on automated insulin delivery. Topics include automated insulin delivery systems, the three main components of AID, hybrid closed loop function, meal related insulin dosing, temporary activity settings, standardized AID reports, prescribing and clinician traini...
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 4) 05.10.2026 7:01
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitoring in the inpatient setting. Topics include the regulatory status of inpatient CGM, guideline support for continued personal sensor use during hospitalization, hybrid CGM and point of care glucose monitoring, clinical outcomes, fac...
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 3) 28.09.2026 7:48
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitoring during pregnancy and the postpartum period. Topics include pregnancy specific CGM targets, time in range and hypoglycemia thresholds, the role of CGM in type 1, type 2, and gestational diabetes, why glucose management indicator...
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 2) 21.09.2026 7:18
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes, focusing on continuous glucose monitoring across key patient populations. Topics include CGM use in insulin treated diabetes, non insulin treated type 2 diabetes, chronic kidney disease, individualized management in CKD, compression lows, the lag between blood and inter...
2026 Consensus Statement on the Use of Diabetes Technology for Management of Adults with Diabetes (Part 1) 14.09.2026 6:44
In this episode, we review the 2026 Consensus Statement on the use of diabetes technology for management of adults with diabetes , focusing on continuous glucose monitoring fundamentals, CGM data quality, time in range targets, and glycemic variability. Topics include CGM components and interstitial glucose measurement, key glucose thresholds, the 5-25-70-4-1 CGM targets, hypoglycemia prioritizati...
GAD65, IAA, IA-2, And ZnT8: Islet Autoantibodies in Type 1 Diabetes 07.09.2026 9:06
In this episode, we review the major islet autoantibodies used in type 1 diabetes, focusing on GAD65 in adults, IAA in young children, IA-2 and progression risk, and ZnT8 for additional diagnostic sensitivity. Topics include antibody testing strategies, presymptomatic screening and staging, single versus multiple autoantibody positivity, type 1 diabetes stages, factors affecting antibody interpret...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Selecting Glucose Lowering Therapy 31.08.2026 14:37
In this episode, we review the 2026 Consensus Statement algorithm for selecting glucose lowering therapy in adults with type 2 diabetes, focusing on cardiovascular, heart failure, kidney, liver, weight, hypoglycemia, adverse effect, and cost considerations. Topics include medication efficacy, cardiovascular and cardiorenal benefits, weight effects, MASLD and MASH, renal dosing, adverse effects, an...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 3) 24.08.2026 10:03
In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes, focusing on the transition beyond basal insulin. Topics include recognizing overbasalization, initiating and titrating prandial insulin, basal bolus insulin therapy, hypoglycemia classification and treatment, glucagon prescribing, the role of CGM in identifying glucose patterns,...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 2) 17.08.2026 9:03
In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes, focusing on basal insulin initiation and titration. Topics include selecting the initial basal insulin dose based on A1C, structured titration strategies, dose reduction for hypoglycemia, titration intervals for different basal insulin preparations, once weekly insulin icodec, r...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Insulin Management (Part 1) 10.08.2026 8:41
In this episode, we review the 2026 Consensus Statement algorithm for insulin management in adults with type 2 diabetes. Topics include individualized glycemic targets, the role of continuous glucose monitoring (CGM), key CGM metrics and glycemic variability, recognition of severe hyperglycemia, when to initiate insulin, the role of GLP-1 based therapy before insulin in clinically stable patients,...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Glucose Centric Management (Episode 10) 03.08.2026 9:42
In this episode, we review the 2026 Consensus Statement algorithm for glucose centric management in adults with type 2 diabetes. Topics include identifying patients appropriate for a glucose centric approach, metformin as foundational therapy, individualized medication selection based on weight, hypoglycemia risk, cost and access, early combination therapy, management of severe hyperglycemia, appr...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Metabolic Dysfunction Associated Steatotic Liver Disease (Episode 9) 27.07.2026 10:24
In this episode, we review the 2026 Consensus Statement algorithm for metabolic dysfunction associated steatotic liver disease (MASLD) management in adults with type 2 diabetes. Topics include the epidemiology and diagnosis of MASLD, progression to metabolic dysfunction associated steatohepatitis (MASH), lifestyle interventions and weight loss goals, the role of resmetirom, GLP-1 receptor agonists...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Stroke and Transient Ischemic Attack (Episode 8) 20.07.2026 8:55
In this episode, we review the 2026 Consensus Statement algorithm for stroke and transient ischemic attack management in adults with type 2 diabetes. Topics include stroke risk in type 2 diabetes, evidence supporting GLP-1 receptor agonists for stroke risk reduction, and cardiovascular outcomes with dulaglutide, liraglutide, injectable semaglutide, tirzepatide, and pioglitazone. We also discuss se...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Atherosclerotic Cardiovascular Disease Management (Episode 7) 13.07.2026 9:35
In this episode, we review the 2026 Consensus Statement ASCVD management algorithm for adults with Type 2 Diabetes. Topics include cardiovascular risk reduction, major adverse cardiovascular events, and the evidence supporting GLP-1 receptor agonists and SGLT2 inhibitors for cardiovascular protection. We discuss semaglutide, liraglutide, dulaglutide, tirzepatide, and the cardiovascular safety of D...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Chronic Kidney Disease Management (Episode 6) 06.07.2026 7:50
In this episode, we review the 2026 Consensus Statement algorithm for the management of chronic kidney disease in adults with Type 2 Diabetes. Topics include SGLT2 inhibitors as foundational renoprotective therapy, evidence based pharmacologic management of diabetic kidney disease, and strategies to reduce CKD progression, kidney failure, and cardiovascular events. We discuss canagliflozin, dapagl...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Heart Failure Management (Episode 5) 29.06.2026 7:19
In this episode, we review the 2026 Consensus Statement algorithm for heart failure management in adults with Type 2 Diabetes. Topics include the foundational role of SGLT2 inhibitors, heart failure with reduced and preserved ejection fraction, and evidence based pharmacologic therapy. We discuss dapagliflozin, empagliflozin, sotagliflozin, GLP-1 receptor agonists, and the role of semaglutide, tir...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Hypertension Management (Episode 4) 22.06.2026 11:40
In this episode, we review the 2026 Consensus Statement hypertension algorithm for adults with Type 2 Diabetes. Topics include blood pressure targets, screening for secondary causes of hypertension, proper blood pressure measurement techniques, lifestyle interventions, and evidence based pharmacologic therapy. We discuss ACE inhibitors, ARBs, thiazide diuretics, calcium channel blockers, resistant...
The 2026 Consensus Statement on the Algorithm for Management of Adults with Type 2 Diabetes: Lipid Management (Episode 3) 15.06.2026 10:43
In this episode, we review the 2026 Consensus Statement on Lipid Management in Adults with Type 2 Diabetes. Topics include ASCVD risk assessment, LDL-C treatment targets, statin therapy, coronary artery calcium scoring, nonstatin lipid lowering therapies, triglyceride management, and key differences between ACC/AHA and AACE recommendations. We also discuss practical treatment strategies and board...
The 2026 Consensus Statement on Diabetes Classification in Adults (Episode 2) 08.06.2026 11:27
In this episode, we review the 2026 Consensus Statement on Diabetes Classification in Adults. Topics include diagnostic criteria for diabetes, distinguishing type 2 diabetes from autoimmune, pancreatogenic, monogenic, endocrinopathy associated, and medication induced diabetes, and the role of phenotype, autoantibody testing, and C-peptide measurement in establishing the correct diagnosis. We also...
The 2026 Consensus Statement on the Algorithm for Management of Adults With Type 2 Diabetes Classification (Episode 1) 01.06.2026 6:50
In this episode, we review the latest 2026 Consensus Statement recommendations for the evaluation and management of prediabetes. Topics include updated diagnostic criteria, the recognition of prediabetes as a cardiometabolic disease state, lifestyle interventions as the foundation of therapy, and strategies to prevent progression to type 2 diabetes. We also discuss comprehensive cardiovascular ris...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.